T0	Participants 114 166	stage III colon cancer (NCCTG N0147 Clinical Trial).
T1	Participants 492 586	patients with stage III colon cancer who enrolled in a phase III clinical trial (NCCTG N0147).
T2	Participants 840 887	between patients defined by LCS6 variant status
T3	Participants 1391 1423	in Caucasians versus other races
T4	Participants 1888 1921	in patients with stage III tumors